SCOPUS 정보 검색 플랫폼

Chinese Journal of Cancer Research

Volumn 22, Issue 1, 2010, Pages 17-20

Clinicopathological characters of triple negative breast cancer

(2) Zhou, Xin a Liu, Qian a

a Chongqing Cancer Institute (China)

Author keywords

Breast cancer; Prognosis; Triple negative

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREMENOPAUSE; PROGNOSIS; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 77249089492 PISSN: 10009604 EISSN: None Source Type: Journal
DOI: 10.1007/s11670-010-0017-8 Document Type: Article

Times cited : (6)

References (14)

1
- 28344454000
- Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
- DOI 10.1200/JCO.2005.03.3845
- J.D. Brenton L.A. Carey A.A. Ahmed, et al. 2005 Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? [J] J Clin Oncol 23 7350 7360 10.1200/JCO.2005.03.3845 1:CAS:528:DC%2BD2MXhtF2nsLrJ 16145060 (Pubitemid 46202348)
- (2005) Journal of Clinical Oncology , vol.23 , Issue.29 , pp. 7350-7360
- Brenton, J.D.¹ Carey, L.A.² Ahmed, A.³ Caldas, C.⁴

2
- 33846266252
- Prognostic markers in triple-negative breast cancer
- DOI 10.1002/cncr.22381
- E.A. Rakha M.E. El-Sayed A.R. Green, et al. 2007 Prognostic markers in triple-negative breast cancer [J] Cancer 109 25 32 10.1002/cncr.22381 1:CAS:528:DC%2BD2sXhtVKrtLY%3D 17146782 (Pubitemid 46120191)
- (2007) Cancer , vol.109 , Issue.1 , pp. 25-32
- Rakha, E.A.¹ El-Sayed, M.E.² Green, A.R.³ Lee, A.H.S.⁴ Robertson, J.F.⁵ Ellis, I.O.⁶

3
- 34248145042
- Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: Results from CALGB 9342
- DOI 10.1186/bcr1622
- L.N. Harris G. Broadwater N.U. Lin, et al. 2006 Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342 [J] Breast Cancer Res 8 R66 10.1186/bcr1622 17129383 (Pubitemid 350201714)
- (2006) Breast Cancer Research , vol.8 , Issue.6
- Harris, L.N.¹ Broadwater, G.² Lin, N.U.³ Miron, A.⁴ Schnitt, S.J.⁵ Cowan, D.⁶ Lara, J.⁷ Bleiweiss, I.⁸ Berry, D.⁹ Ellis, M.¹⁰ Hayes, D.F.¹¹ Winer, E.P.¹² Dressler, L.¹³

4
- 34547661993
- Triple-negative breast cancer: Clinical features and patterns of recurrence
- DOI 10.1158/1078-0432.CCR-06-3045
- R. Dent M. Trudeau K.I. Pritchard, et al. 2007 Triple-negative breast cancer: clinical features and patterns of recurrence [J] Clin Cancer Res 13 15Pt1 4429 4434 10.1158/1078-0432.CCR-06-3045 17671126 (Pubitemid 47219710)
- (2007) Clinical Cancer Research , vol.13 , Issue.15 , pp. 4429-4434
- Dent, R.¹ Trudeau, M.² Pritchard, K.I.³ Hanna, W.M.⁴ Kahn, H.K.⁵ Sawka, C.A.⁶ Lickley, L.A.⁷ Rawlinson, E.⁸ Sun, P.⁹ Narod, S.A.¹⁰

5
- 34247569300
- Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California Cancer Registry
- DOI 10.1002/cncr.22618
- K.R. Bauer M. Brown R.D. Cress, et al. 2007 Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry [J] Cancer 109 1721 1728 10.1002/cncr.22618 17387718 (Pubitemid 46668532)
- (2007) Cancer , vol.109 , Issue.9 , pp. 1721-1728
- Bauer, K.R.¹ Brown, M.² Cress, R.D.³ Parise, C.A.⁴ Caggiano, V.⁵

6
- 34247381115
- Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
- DOI 10.1200/JCO.2006.06.5664
- B.G. Haffty Q. Yang M. Reiss, et al. 2006 Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer [J] J Clin Oncol 24 5652 5657 10.1200/JCO.2006.06.5664 17116942 (Pubitemid 46631305)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.36 , pp. 5652-5657
- Haffty, B.G.¹ Yang, Q.² Reiss, M.³ Kearney, T.⁴ Higgins, S.A.⁵ Weidhaas, J.⁶ Harris, L.⁷ Hait, W.⁸ Toppmeyer, D.⁹

7
- 33645072444
- Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas [J]
- 10.1158/1078-0432.CCR-05-2281
- S.M. Rodríquez-Pinilla D. Sarrió E. Honrado, et al. 2006 Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas [J] Clin Cancer Res 12 1533 1539 10.1158/1078-0432.CCR-05-2281
- (2006) Clin Cancer Res , vol.12 , pp. 1533-1539
- Rodríquez-Pinilla, S.M.¹ Sarrió, D.² Honrado, E.³

8
- 47549107072
- Triple negative breast cancer: Molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
- DOI 10.1007/s10549-007-9756-8
- D.S. Tan C. Marchió R.L. Jones, et al. 2008 Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients [J] Breast Cancer Res Treat 111 27 44 10.1007/s10549-007-9756-8 1:CAS:528:DC%2BD1cXos1Wnsbs%3D 17922188 (Pubitemid 352009225)
- (2008) Breast Cancer Research and Treatment , vol.111 , Issue.1 , pp. 27-44
- Tan, D.S.P.¹ Marchio, C.² Jones, R.L.³ Savage, K.⁴ Smith, I.E.⁵ Dowsett, M.⁶ Reis-Filho, J.S.⁷

9
- 33847035558
- BRCA1, a potential predictive biomarker in the treatment of breast cancer
- DOI 10.1634/theoncologist.12-2-142
- C.R. James J.E. Quinn P.B. Mullan, et al. 2007 BRCA1, a potential predictive biomarker in the treatment of breast cancer [J] Oncologist 12 142 150 10.1634/theoncologist.12-2-142 1:CAS:528:DC%2BD2sXjtFChsLo%3D 17296808 (Pubitemid 46271614)
- (2007) Oncologist , vol.12 , Issue.2 , pp. 142-150
- James, C.R.¹ Quinn, J.E.² Mullan, P.B.³ Johnston, P.G.⁴ Harkin, D.P.⁵

10
- 33744960226
- Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
- DOI 10.1001/jama.295.21.2492
- L.A. Carey C.M. Perou C.A. Livasy, et al. 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J] JAMA 295 2492 2502 10.1001/jama.295.21.2492 1:CAS:528:DC%2BD28XlsV2rtLw%3D 16757721 (Pubitemid 43854964)
- (2006) Journal of the American Medical Association , vol.295 , Issue.21 , pp. 2492-2502
- Carey, L.A.¹ Perou, C.M.² Livasy, C.A.³ Dressler, L.G.⁴ Cowan, D.⁵ Conway, K.⁶ Karaca, G.⁷ Troester, M.A.⁸ Chiu, K.T.⁹ Edmiston, S.¹⁰ Deming, S.L.¹¹ Geradts, J.¹² Cheang, M.C.U.¹³ Nielsen, T.O.¹⁴ Moorman, P.G.¹⁵ Earp, H.S.¹⁶ Millikan, R.C.¹⁷

11
- 34548484801
- BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers
- DOI 10.1038/sj.onc.1210420, PII 1210420
- C. Yuli N. Shao R. Rao, et al. 2007 BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers [J] Oncogene 26 6031 6037 10.1038/sj.onc.1210420 1:CAS:528:DC%2BD2sXpvFWmtb0%3D 17384678 (Pubitemid 47373802)
- (2007) Oncogene , vol.26 , Issue.41 , pp. 6031-6037
- Yuli, C.¹ Shao, N.² Rao, R.³ Aysola, P.⁴ Reddy, V.⁵ Oprea-Llies, G.⁶ Lee, L.⁷ Okoli, J.⁸ Partridge, E.⁹ Reddy, E.S.P.¹⁰ Rao, V.N.¹¹

12
- 31044433169
- αB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer
- DOI 10.1172/JCI25888
- J.V. Moyano J.R. Evans F. Chen, et al. 2006 Alpha B-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer [J] J Clin Invest 116 261 270 10.1172/JCI25888 1:CAS:528:DC%2BD28XjslOgtA%3D%3D 16395408 (Pubitemid 43121811)
- (2006) Journal of Clinical Investigation , vol.116 , Issue.1 , pp. 261-270
- Moyano, J.V.¹ Evans, J.R.² Chen, F.³ Lu, M.⁴ Werner, M.E.⁵ Yehiely, F.⁶ Diaz, L.K.⁷ Turbin, D.⁸ Karaca, G.⁹ Wiley, E.¹⁰ Nielsen, T.O.¹¹ Perou, C.M.¹² Cryns, V.L.¹³

13
- 33746708760
- Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer
- DOI 10.1007/s10549-006-9184-1
- S.M. Pinilla E. Honrado D. Hardisson, et al. 2006 Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer [J] Breast Cancer Res Treat 99 85 90 10.1007/s10549-006-9184-1 1:CAS:528:DC%2BD28XnslShsbo%3D 16541313 (Pubitemid 44168607)
- (2006) Breast Cancer Research and Treatment , vol.99 , Issue.1 , pp. 85-90
- Rodriguez Pinilla, S.M.¹ Honrado, E.² Hardisson, D.³ Benitez, J.⁴ Palacios, J.⁵

14
- 33846587923
- The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies
- DOI 10.1016/j.breast.2006.09.003, PII S0960977606001858
- K.P. Siziopikou M. Cobleigh 2007 The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies [J] Breast 16 104 107 10.1016/j.breast.2006.09.003 17097880 (Pubitemid 46172864)
- (2007) Breast , vol.16 , Issue.1 , pp. 104-107
- Siziopikou, K.P.¹ Cobleigh, M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.